Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Clinical trial NCT01145859 · COMPLETED

Trial details

NCT number: NCT01145859
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Venous Thrombosis Pediatrics

Start date: 2010-11-01
Primary completion: 2015-07-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.